- Report
- May 2026
- 529 Pages
Global
From €5166EUR$5,850USD£4,462GBP
- Report
- May 2026
- 216 Pages
Global
From €5166EUR$5,850USD£4,462GBP
- Report
- February 2026
- 250 Pages
Global
From €3965EUR$4,490USD£3,425GBP
- Report
- February 2026
- 250 Pages
Global
From €3965EUR$4,490USD£3,425GBP
- Report
- February 2026
- 250 Pages
Global
From €3965EUR$4,490USD£3,425GBP
- Report
- February 2026
- 250 Pages
Global
From €3965EUR$4,490USD£3,425GBP
- Report
- February 2026
- 250 Pages
Global
From €3965EUR$4,490USD£3,425GBP
- Report
- November 2025
- 150 Pages
Global
From €3311EUR$3,750USD£2,860GBP
- Report
- May 2026
- 180 Pages
Global
From €3974EUR$4,500USD£3,432GBP
- Report
- May 2026
- 192 Pages
Global
From €3974EUR$4,500USD£3,432GBP
- Report
- January 2026
- 181 Pages
Global
From €3974EUR$4,500USD£3,432GBP
- Report
- January 2026
- 182 Pages
Global
From €3974EUR$4,500USD£3,432GBP
- Report
- January 2026
- 180 Pages
Global
From €3974EUR$4,500USD£3,432GBP
- Report
- January 2026
- 185 Pages
Global
From €3974EUR$4,500USD£3,432GBP
- Report
- June 2025
- 183 Pages
Global
From €3974EUR$4,500USD£3,432GBP
- Report
- July 2025
- 350 Pages
Global
From €4370EUR$4,949USD£3,775GBP
- Report
- July 2025
- 350 Pages
Global
From €4370EUR$4,949USD£3,775GBP
- Report
- October 2025
- 147 Pages
Global
From €3531EUR$3,999USD£3,050GBP
- Report
- September 2025
- 141 Pages
Global
From €3531EUR$3,999USD£3,050GBP
- Report
- August 2025
- 136 Pages
Global
From €3531EUR$3,999USD£3,050GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more